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Cartography of opportunistic pathogens and
antibiotic resistance genes in a tertiary hospital
environment
Kern Rei Chng1,60, Chenhao Li 1,60, Denis Bertrand1,60, Amanda Hui Qi Ng1, Junmei Samantha Kwah1,
Hwee Meng Low1, Chengxuan Tong1, Maanasa Natrajan1, Michael Hongjie Zhang1, Licheng Xu2,
Karrie Kwan Ki Ko3,4,5, Eliza Xin Pei Ho1, Tamar V. Av-Shalom1, Jeanette Woon Pei Teo6,
Chiea Chuen Khor 1, MetaSUB Consortium*, Swaine L. Chen1, Christopher E. Mason 7,
Oon Tek Ng8,9,10, Kalisvar Marimuthu 8,9,11, Brenda Ang8,9 and Niranjan Nagarajan 1,11 ✉
Although disinfection is key to infection control, the colonization patterns and resistomes of hospital-environment microbes
remain underexplored. We report the first extensive genomic characterization of microbiomes, pathogens and antibiotic resistance cassettes in a tertiary-care hospital, from repeated sampling (up to 1.5 years apart) of 179 sites associated with 45 beds.
Deep shotgun metagenomics unveiled distinct ecological niches of microbes and antibiotic resistance genes characterized
by biofilm-forming and human-microbiome-influenced environments with corresponding patterns of spatiotemporal divergence. Quasi-metagenomics with nanopore sequencing provided thousands of high-contiguity genomes, phage and plasmid
sequences (>60% novel), enabling characterization of resistome and mobilome diversity and dynamic architectures in hospital
environments. Phylogenetics identified multidrug-resistant strains as being widely distributed and stably colonizing across
sites. Comparisons with clinical isolates indicated that such microbes can persist in hospitals for extended periods (>8 years),
to opportunistically infect patients. These findings highlight the importance of characterizing antibiotic resistance reservoirs in
hospitals and establish the feasibility of systematic surveys to target resources for preventing infections.

T

he global epidemic of antibiotic resistance has refocused
attention on infection prevention and control in hospitals1. It is estimated that if the spread of antibiotic resistance
grows unchecked, it will cause millions of deaths worldwide, with
an economic impact of more than US$100 trillion by 2050 (ref. 2).
Hospital-acquired infections (HAIs) pose a high healthcare burden
in both developed and developing countries3. US estimates highlight
that 1 in 25 acute-care patients have active HAIs daily (721,800 HAIs
each year), with 11.5% of patients dying during hospitalization4.
The problem of HAIs is further compounded by the global spread
of multidrug-resistant organisms (MDROs), complicating infection
management, limiting therapy options and resulting in poorer outcomes5. The risk of HAIs can be mitigated through good infection
prevention practice, with hand hygiene advocated as an important
strategy to limit spread between patients and medical staff6.
In addition to human-to-human transfer, the hospital environment is another key transmission network node, with mounting
evidence that it harbors opportunistic antibiotic-resistant pathogens
contributing to HAIs7. Reinforced environmental cleaning measures
have shown effectiveness in reducing HAIs8. The microbial ecology
and uncharacterized genetic reservoirs of hospital environments are

thus of interest for both infection epidemiology and microbiology.
For example, transmission and recombination profiles of antibiotic
resistance genes (ARGs) in hospitals remain largely unknown and
could help gauge risk for emergence of novel resistance combinations. Similarly, comparative genomics of hospital-adapted and
epidemic strains could identify the source of outbreaks and inform
infection control. While large-scale surveillance holds promise
to reveal clinical and biological insights pertaining to the hospital microbiome as a reservoir of pathogens and ARGs, significant
technological challenges remain. Traditionally, efforts to survey
the hospital environment have focused on culture-based isolation
of specific pathogens, with each isolate individually characterized
via functional profiling, genotyping and/or whole-genome sequencing9–11. This is laborious, is prone to isolation bias and precludes
insights into overall community structure and how that interacts
with the built environment to impact HAIs12.
The development of metagenomics enables profiling of overall
community structure, characterizing individual microbes without
isolation, and represents a scalable, high-throughput method for surveying hospital environments13. This has been leveraged through 16S
rRNA sequencing in early studies of bacterial diversity, particularly
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in intensive care units (ICUs)14. Lax et al. used this approach to
extensively characterize microbial ecology, colonization and succession in a newly built hospital15. Using bioinformatics approaches,
the authors identified ecological signatures of bacterial exchange
between the environment, patients and healthcare workers.
However, 16S rRNA sequencing precludes detailed analysis of nosocomial strains, resistomes, metabolic pathways and transmission of
pathogenomes16. Brooks et al. used Illumina shotgun metagenomics
to characterize strain polymorphisms and relatedness of pathogens
in low-diversity neonatal ICU environments17. Several limitations
remain for the use of shotgun metagenomics in general, including
low biomass, the presence of multiple strains and pathogens at low
abundances, inaccuracies in strain-level analysis18, and shortcomings of short reads for assembling high-contiguity, strain-resolved
genomes for detailed genetic analyses19.
The availability of long-read sequencing presents new opportunities and challenges for pathogenome and resistome monitoring20.
Here, we combined extensive short-read shotgun metagenomics
of multiple sites, wards and time points (n = 428) with enrichment
and nanopore sequencing of antibiotic-resistant mixed cultures
(n = 1,661) to provide the most extensive genetic characterization
of hospital environments to date. The combination of metagenomic surveys (short-read based) with detailed genomic analysis
of nosocomial strains (long-read based) is ideal for studying distribution, abundance and turnover patterns of pathogens and
ARGs. Nanopore metagenomics enabled the generation of thousands of high-contiguity genomes (n = 2,347), phage sequences
(n = 1,693) and closed plasmid sequences (n = 5,910), revealing substantial uncharacterized genetic diversity (>60% novel).
These were harbored in distinct ecological niches characterized by
biofilm-forming and human-microbiome-associated bacteria, with
divergent patterns of spatiotemporal variation. Phylogenetic analysis highlighted that MDROs are more likely to be widely distributed
and stably colonizing across hospital sites. Analysis of ARG combinations and phage and plasmid architectures revealed the dynamic
nature of hospital-environment resistomes. Genomic comparisons
with patient isolates across multiple species indicated that MDROs
persist in the hospital environment for extended periods (>8 years)
to opportunistically infect patients. These findings underscore the
importance of characterizing hospital microbiomes to understand
niches and genetic reservoirs, the need for improved disinfection
methods and the feasibility of large-scale genomic surveys to inform
infection control.

Results

Hospital-environment microbiomes offer distinct ecological
niches for opportunistic pathogens and ARGs. A diverse set of
sites (n = 7) of concern for infection control21,22 and different room
types distributed around the building (5 single-bed isolation rooms
together with 4 MDRO and 4 standard five-bed wards) were
selected for initial sampling at two time points (1 week apart) of a
tertiary-care hospital in Singapore (45 beds (4% of total), 179 sites,
358 samples; Fig. 1a and Supplementary Data 1). Illumina shotgun
metagenomics (2 × 101 bp) was used to deeply characterize each
sample (average = 30 × 106 reads; 3 of 358 libraries were excluded
due to low biomass) to obtain taxonomic profiles and resistomes
(Fig. 1b, Supplementary Data 2 and Methods). Controls, spike-ins
and validation experiments were used to assess and account for the
impact of kit contaminants on low-biomass samples23, with likely
contaminants identified using batch and correlation analysis23
and filtered from profiles (Supplementary Note 1, Supplementary
Data 2 and Methods). Taxonomic profiles were visualized using a
principal-coordinates analysis (PCoA) plot to identify two distinct
microbial community configurations in the hospital environment
(Fig. 2a). While community type A (CTA) sites were more taxonomically diverse (Wilcoxon P value < 10−3; Supplementary Fig. 1) and
942

largely high-touch surfaces with frequent contact from patients and
healthcare workers24, community type B (CTB) represents sites of
increasing concern for infection control for their propensity to harbor MDROs10,21,25. Joint analysis of these community types helped
to identify key taxonomic features that differentiate them, including several human-microbiome-associated genera (for example,
Cutibacterium) and aquatic and terrestrial environment-associated
genera (for example, Achromobacter) in CTA and CTB, respectively, although not all genera could be defined in these terms
(for example, Pseudomonas, Acinetobacter and Ralstonia; Fig. 2b).
At the species level, key differences included enrichment of common
skin bacteria (for example, Cutibacterium acnes and Staphylococcus
epidermidis) and biofilm-associated organisms in hospitals (for
example, Elizabethkingia anophelis and Serratia marcescens) in
CTA and CTB sites, respectively, although their occurrences were
not mutually exclusive, indicating shared influences (Fig. 2c). The
comparison of hospital microbiome CTA and CTB sites to similar
sites in an indoor office environment (n = 30, office; Supplementary
Data 1 and Methods) and other high-touch environmental microbiomes26 (n = 99, MetaSUB Singapore; Supplementary Data 1) further
highlighted the distinctness of hospital environments and community types (Supplementary Fig. 2) and the corresponding utility as
an organizing principle for studying clinical impact14,27.
Microbiomes associated with the community types exhibited varying stability across the sampled time points, with CTA
sites demonstrating larger fluctuations (except door handles;
Wilcoxon P value < 10−3; Fig. 2d). Microbial profiles diverged with
distance (within a bed, within wards and across wards) and time
(1 week apart), with temporal variability within a week being lower
than spatial variability within a ward (Wilcoxon P value < 10−3;
Supplementary Fig. 3a). Analysis of a subset of sites (n = 80) resampled at a third time point >1 year later confirmed long-term stability
of community types across sites (Supplementary Fig. 3b). Microbial
composition of sites is expected to be influenced by several factors,
including abiotic conditions (humidity, temperature and surface
type), seeding from microbial reservoirs (human or environmental)
and exchange across sites. Based on sequencing data, we computed
scores to quantify these factors, including a microbiome turnover
index (fraction of taxa gained or lost across time points), a human
influence index (fraction of human reads) and a site specificity
index (uniqueness of site-specific taxonomic composition relative
to proximal sites), each of which exhibited significantly correlated
trends across time points (Supplementary Fig. 4a). The computed
indices reinforce the notion that CTB sites (primarily sink traps
and aerators) have stable compositions (low turnover) based on
site-specific biofilm configurations with limited human microbiome seeding (Fig. 2e). CTA sites showed higher human influence
(Wilcoxon P value < 10−15) and microbiome turnover (Wilcoxon
P value < 10−4) indices, although they were not directly correlated,
and showed weaker site specificity (Wilcoxon P value < 10−12), concordant with a model where human activities (patient discharge and
admittance events) have a systemic role in shaping site compositions (Fig. 2e). Species that were enriched in CTA sites were also
observed in CTB sites (and vice versa) but had higher turnover in
these cases (Supplementary Fig. 4b), with some exceptions such as
Siphoviridae, which had high turnover in both CTA and CTB sites.
Overall, patterns of microbiome variability were consistent
across ward types, although isolation rooms exhibited lower variability across time points (Supplementary Fig. 5). In line with
Singapore’s MDRO management guidelines28, patients colonized
with carbapenem-resistant Enterobacteriaceae (CRE; for example, Klebsiella pneumoniae) were typically in single-bed isolation
rooms, while patients with methicillin-resistant Staphylococcus
aureus (MRSA) were in MDRO wards. An analysis of differentially
abundant nosocomial pathogens (curated from https://www.cdc.
gov/hai/organisms/organisms.html and publications4,29) detected
Nature Medicine | VOL 26 | June 2020 | 941–951 | www.nature.com/naturemedicine
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Fig. 1 | Overview of sampling sites and analysis workflow. a, Diagram showing the various sites that were sampled, including cardiac tables (A), bed rails
(B), pulse oximeters (C), bedside lockers (D), sink aerators (E), sink traps (F) and door handles (G). Each ward (MDRO and standard) had five beds (sites
A–D individually sampled), one sink (E,F) and no doors, while isolation rooms had one bed (A–D), one sink (E,F) and a door (G). b, Diagram showing the
analysis workflow for the four swabs that were collected from each site in terms of culturing, DNA extraction and sequencing. Samples from each site were
analyzed with shotgun metagenomic sequencing on the Illumina platform and multiple (n = 6) culture-enriched quasi-metagenomics on a GridION system.

across ward types identified K. pneumoniae and S. aureus as being
enriched in CTA sites for isolation rooms and MDRO wards,
respectively, providing further evidence for the influence of patient
microbiomes on CTA sites (Fig. 2f). Consistent with observed taxonomic differences, CTA and CTB sites harbored distinct complements of ARGs in their resistomes (Fig. 2g and Supplementary
Fig. 6). While some ARGs were frequently detected in CTB sites
(for example, ges and oxa-7; Fig. 2g), CTA sites carried a wider
diversity of ARGs at lower frequencies. Despite recent focus on
CTB sites as ARG reservoirs10,25, some clinically important ARGs
such as oxa-23 (encoding a carbapenemase) and mecA (methicillin
resistance) were more frequently found in CTA sites, while genes
such as imp-1 (carbapenemase) and cme-1 (extended-spectrum
beta-lactamase) were more common in CTB sites. Different sites
also exhibited distinct resistome patterns—for example, specific
tetracycline (tetC) and macrolide (mphE) resistance genes were
highly enriched only in aerators, while vancomycin resistance genes
were only observed in bedside lockers and on bed rails—highlighting the importance of considering site- and ward-specific patterns
for infection control and drug resistance mitigation strategies
(Supplementary Fig. 6). While a higher proportion of ARGs was
consistently detected across time points in CTB sites compared to
CTA sites (Supplementary Fig. 7a), overall, hospital microbiomes
exhibited significantly higher abundance (>3-fold versus MetaSUB
Singapore and >12-fold versus office sites, Wilcoxon P value < 10−15
for both comparisons; Supplementary Fig. 7b) and higher diversity (Wilcoxon P value < 10−15; Supplementary Fig. 7c) of ARGs

compared to other high-touch urban environmental microbiomes.
Even though the presence of ARGs does not always translate to
resistance phenotypes, these results further underscore the distinctness of hospital microbiomes as ARG reservoirs30.
Quasi-metagenomics with nanopore sequencing reveals distribution of multidrug-resistant opportunistic pathogens in the
hospital environment. Based on Illumina metagenomic profiles,
we noted that nosocomial pathogens were generally present at low
relative abundances (median relative abundance < 0.5%; Fig. 3a) in
hospital environments (even though this was higher than in other
urban sites; Supplementary Fig. 7d), precluding detailed genomic
characterization of transmission patterns, ARG combinations
and plasmids. The distribution of common pathogens exhibited
site-specific patterns (PERMANOVA P value < 0.001; Fig. 3a), in
agreement with the distinct niches observed in hospital environments (Fig. 2a–c), and indicated that enrichment cultures could
capture a diverse set of species. We exploited this observation to
use a culturing, antibiotic selection (five antibiotics) and metagenomic nanopore sequencing approach (Fig. 1b) to obtain a large
database of high-contiguity assemblies (n = 2,347) from the hospital
environment (median N50 > 1 Mb; Fig. 3b, Supplementary Data 3
and Methods), expanding substantially on genomic resources
established by previous studies10,11. Overall, a large percentage of
sites led to viable cultures (>95%), with antibiotic selection resulting in growth in >80% of plates (1,495 of 1,790) and >42% of sites
resulting in cultures for all five antibiotics. Control swabs led to no
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Fig. 2 | Distinct ecological niches in the hospital environment for microbes and ARGs. a, PCoA plot based on genus-level Bray–Curtis dissimilarity of
taxonomic profiles (n = 176 independent samples, time point 1) indicating two distinct community types (denoted as CTA and CTB) for microbiomes from
the hospital environment. b, Heat map showing relative abundances (log-scale, log2 (RA)) for differentially abundant genera between CTA and CTB (false
discovery rate (FDR)-adjusted two-sided Wilcoxon P value < 0.01; n = 151 and 25 independent samples for CTA and CTB sites, respectively). c, Box plots
showing relative abundances for differentially abundant species between CTA and CTB (FDR-adjusted two-sided Wilcoxon P value < 0.01; n = 151 and 25
independent samples for CTA and CTB sites, respectively). In the box plots, the center line is the median; box limits are the upper and lower quartiles; and
whiskers are 1.5 times the interquartile range (outlier points are not included in the visualization). d, PCoA plots (genus-level Bray–Curtis dissimilarity)
showing variation in environmental microbiomes over time (lines connect two time points, 1 week apart) for different sites (n = 24, 26, 90, 90, 90, 10 and
22 independent samples for sink traps, aerators, bed rails, bedside lockers, cardiac tables, door handles and pulse oximeters, respectively). e, Radar plot
showing the microbiome turnover index (fraction of taxa that are gained or lost across time points), human influence index (fraction of human reads)
and site specificity index (uniqueness of site-specific taxonomic composition in relation to physically proximal sites). A positive site-specificity index
indicates a stronger site-specific microbiome composition signature. f, Box plots showing relative abundances of common nosocomial pathogens that
were differentially abundant across ward types in sites with high human contact (FDR-adjusted Kruskal–Wallis test, P value < 0.01; n = 48, 128 and 128
independent samples for isolation rooms, MDRO wards and standard wards, respectively). In the box plots, the center line is the median; box limits are the
upper and lower quartiles; and whiskers are 1.5 times the interquartile range (outlier points are not included in the visualization). g, Heat map depicting the
frequency of detection for beta-lactamases at different sites in hospital wards. Multiple carbapenemases and the mecA gene were detected as part of the
resistomes that were primarily defined by the community types (CTA and CTB).

cultures (0 of 10), confirming that cultures were not likely due to
contamination (Methods), and further testing of isolates confirmed
that the vast majority of strains in the cultures were likely to be antibiotic resistant (99%; Supplementary Note 2).
DNA was extracted from 1,661 plates and sequenced on a
GridION to provide 535 Mb of data on average per sample (median
read length > 2.5 kb). Long-read metagenomic assembly enabled
the reconstruction of megabase-pair sized contigs (versus average
N50 < 5 kb for Illumina assemblies) as the communities were largely
simple (Supplementary Fig. 8, Fig. 3b and Methods). Evaluation of
these draft genomes based on conserved single-copy genes confirmed that they were of high quality (completeness > 99%, contamination < 0.5%; Methods). In total, we obtained genomes for 69
species from the hospital environment, 40% of which belonged to
common pathogens (Methods). Our results confirm the viability
of these species in different hospital environments and the ability
944

to enrich them for sequencing and genome reconstruction despite
their low abundances in hospital microbiomes (median relative
abundance = 0.68%, averaged across species; Fig. 3c). Large-scale
homology analysis with public databases31–33 also helped to identify
13 (out of >80) species-level clusters (11 different genera including
Bacillus, Pseudomonas and Staphylococcus) with no representatives
from known species, highlighting recovery of high-quality genomes
for novel species using this approach (Methods). Rarefaction analysis showed that >90% of the species and resistance gene diversity
(>50% richness) that could be sampled from sites in this study was
captured by our sample size (Supplementary Fig. 9), while substantial additional diversity remains to be captured for plasmids and
HAI-associated strains (Supplementary Note 3). This confirms the
viability of future surveys of ARGs in hospitals with much fewer
samples (n ≈ 50), making regular surveys feasible, affordable and
potentially actionable.
Nature Medicine | VOL 26 | June 2020 | 941–951 | www.nature.com/naturemedicine
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Fig. 3 | Genome-resolved characterization of nosocomial multidrug-resistant strains that spread and persist at low relative abundances in the hospital
environment. a, Heat map displaying the distinct median relative abundance (RA) of common nosocomial pathogens at different sites (n = 26, 90, 90, 90,
10, 22 and 24 for aerators, bed rails, bedside lockers, cardiac tables, door handles, pulse oximeters and sink traps, respectively) in hospital environments
(PERMANOVA P value < 0.001). b, Distribution of assembly contiguity statistics (N50 = fragment size such that more than 50% of the genome is in
longer sequences) for common nosocomial pathogens, highlighting the high genomic contiguity that was obtained (median N50 > 1 Mb). c, Dot plots
highlighting that genomes can be rapidly obtained for several nosocomial pathogens despite their low relative abundances in corresponding environmental
microbiomes (y axis) through an enrichment and long-read metagenomic sequencing-based protocol. Represented species are associated with more than
20 genome drafts in the overall database of 2,347 genomes. d, Left, phylogenetic relationships of S. aureus derivative clusters (>99.99% ANI; each node
represents the consensus genome for the cluster) detected in the hospital environment together with their antibiotic resistance profiles. The scale bar
represents the number of substitutions per site in the core alignment. Right, hive map representation showing localization of S. aureus clusters that spread
(detected at two or more locations) and/or persist (detected in time points 1 and 2) in the hospital environment. The colored lines represent occurrence at
time point 1 (orange) and time point 2 (blue); line thickness represents the number of instances of such occurrences. Note that multidrug-resistant strains
such as s3, s2 and s1 tend to be more widely distributed and persistent in the hospital environment.

As plasmids and phages serve as an important medium for
the evolution and spread of ARGs and emergence of multidrug
resistance34,35, we characterized corresponding sequences in our
genomic database (Methods). In total, we recovered 696 Mb of
plasmid sequences (n = 5,910 closed and 493 Mb of linear fragments) and 63 Mb of phage sequences (n = 1,693, of which 277
are circular), most of which are not present in existing databases
for plasmids36 or phages37 (>90%; 1,505 of 1,588 plasmid clusters
and 501 of 557 phage clusters; Methods) despite being commonly
distributed in the hospital (Supplementary Fig. 10), highlighting
its underexplored genetic diversity. Many closed plasmids were
>100 kb long (>9%, n = 536), rich in repeats and present at low
abundance, impeding characterization using Illumina metagenomics. We noted the presence of several large mecA-carrying
plasmids that contained antiseptic or disinfectant resistance genes
(qacA or qacC), a combination that is not represented in existing databases36 but is in agreement with high biocide resistance
for MRSA in clinical settings38. One of the plasmids had genes
from several additional ARG classes that have not been seen in
combination (for example, dfrC, lnuA and aac6-Aph2), highlighting the value of closed sequences for characterization of novel
ARG combinations.

The availability of a large collection of highly contiguous plasmid (closed) and chromosomal (megabase-pair contigs) assemblies
allowed us to perform genomic relatedness (with environmental
and patient strains) and structural (common gene cassettes and
exchange across cassettes) analysis. We first analyzed evolutionary relationships between genomes from the hospital, with previously used thresholds of average nucleotide identity (ANI) to
define strain-level39 (>99.9% ANI), derivative10 (>99.99% ANI) and
direct-transfer17 (>99.999% ANI) genome clusters, and understand
their spatiotemporal distribution. For many species, a diverse set of
clusters was observed across the hospital (n = 6, Pseudomonas aeruginosa to n = 46, S. epidermidis; Fig. 3d and Supplementary Fig. 11).
Some genome clusters were frequently detected at multiple sites and
ward types in the hospital, and these were also significantly enriched
for clusters detected in the first and second time points (Fisher’s
exact test P value < 1.5 × 10−9). Even at the most stringent threshold (direct transfer), a substantial fraction of genomes observed in
the third time point (1.5 years later) clustered with genomes from
earlier time points for various species (E. anophelis: 92%, as few as
5 single nucleotide polymorphisms (SNPs); S. marcescens: 20%, 16
SNPs; Staphylococcus haemolyticus: 21%, 8 SNPs), emphasizing the
stability of environmental pathogenomes.
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Overlaying antibiotic resistance information with these patterns,
we noted an enrichment of multiantibiotic resistance among strains
that were widely distributed through space and time (>2 antibiotics; Fisher’s exact test P value < 3 × 10−8; Fig. 3d and Supplementary
Fig. 12). This was also consistently observed across several common
pathogens in the hospital (Fisher’s exact test P value: 1.6 × 10−2, S.
aureus; 2.3 × 10−3, S. epidermidis; 3.7 × 10−3, Enterococcus faecalis;
5.0 × 10−2, Acinetobacter baumannii). For a subset of species
(S. aureus, S. epidermidis and A. baumannii), we used Illumina
sequencing to generate hybrid assemblies and reliably detect derivative and direct-transfer relationships (Methods). Genomes that
were related across early time points based on these stringent criteria continued to be significantly enriched for multidrug resistance (binomial test P value < 10−5, all species and both thresholds)
and were also enriched in the third time point (derivative clusters,
binomial test P value: 0.028, S. epidermidis; 5.0 × 10−5, S. aureus),
highlighting the presence of stable, viable environmental reservoirs
for pathogens and the need to understand the mechanisms contributing to enrichment of multidrug-resistant strains40,41.
Diversity and dynamics of ARG cassettes in the hospital environment. With increasing multidrug resistance, the specific combination of ARGs that is harbored is important to know from
a clinical perspective. In hospital environments, little is known
about the diversity of ARG combinations and genetic exchange
across genomic cassettes and plasmids. Comparing our database of
2,347 high-contiguity genomes and 5,910 closed plasmids against
existing databases, we found that 34% of the ARG combinations
observed were novel (255 of 752; Supplementary Data 4). Certain
ARG combinations have obvious clinical importance, for example,
the co-occurrence of mecA with fosB (fosfomycin resistance) in
several environmental S. aureus strains, an observation that is concerning given the potential utility of fosfomycin for treating MRSA
infections42. Notably, we detected Enterobacteriaceae-associated
genes that can confer resistance to gentamicin (aac3-IIa), fosfomycin (fosA, fosA2) and colistin (mcr1), all last-resort antibiotics for
CRE infections. Additionally, two Enterobacteriaceae-associated
plasmids, one carrying fosA and the other carrying mcr1, were
obtained from the same bedside locker, highlighting the potential reservoir for emergence of co-resistance to colistin and fosfomycin. Another Enterobacteriaceae-associated plasmid carried
a rifampicin resistance gene (arr), a telling observation given
the growing interest in using rifampicin in combination treatments for a variety of Gram-negative infections, for example,
A. baumannii43,44.
We next identified common ARG pairs that were in close proximity (<10 kb apart) to determine chromosomal cassettes that may
serve as the unit of evolution, co-regulation and ARG exchange
(Methods). Chromosomal cassettes were generally small (2–6
genes, average = 3) and specific to a species, although two large cassettes carrying extended-spectrum beta-lactamases were found to
overlap for K. pneumonia and Enterobacter cloacae (KpnC1, KpnC2
and EclC1, EclC2; KpnC3 and EclC3; Fig. 4a and Supplementary
Data 5). Selective pressure from rampant use of beta-lactams and
plasmid-mediated transmission could have contributed to the sharing of these large cassettes across species. Cassettes for Gram-negative
species were larger and more stable (solid lines to genes), while those
for Gram-positive species were smaller with many variably present
members (dashed lines to genes). The largest shared cassette among
Gram-positive species (aminoglycoside-streptothricin resistance;
ant6-Ia, sat4A and aph3-III) was in Enterococcus and Staphylococcus
but with no discernible signals of mobile elements45. While most
genes were stably present in cassettes, with some exceptions (for
example, tetK, far1 and catA), the exchange of genes across cassettes
was rarely observed (for example, blaZ), indicating that chromosomal cassettes tend to be relatively fixed.
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Performing a similar analysis for closed plasmids, we first clustered them into shared backbones and annotated them for known
hosts (identity ≥ 95%; Methods). By analyzing ARGs in this context, we found that many ARGs were variably present in backbones
(93 of 143). For ARGs stably found in one backbone, many were
variably present in another backbone (19 of 31), highlighting the
dynamic nature of ARG combinations from plasmids in the hospital
environment (Fig. 4b). Despite this, some ARG combinations were
stably present in multiple plasmid backbones, indicating strong
selection for coexistence. For example, the genes strA, strB (streptomycin resistance) and sulII (sulfonamide resistance) co-occurred in
two distinct backbones (Sen1 and Kpn2, sequence overlap < 54%),
likely as a signature from past co-administration of streptomycin
and sulfonamides46,47. Similarly, while aminoglycoside resistance
genes such as aadD and aac6-Aph2 were widely distributed across
plasmid backbones, ant6-Ia and aph3-III were stably shared by
two distinct backbones (Efa4 and Efs1, sequence overlap <11%)
indicating that they may provide synergistic resistance to aminoglycosides by catalyzing different modifications. Notably, genes that
are widely distributed across plasmids (for example, tetK, far1 and
blaZ) can come together in a novel, clinically relevant backbone
(Fig. 4b; Slu3, with 38 sequences in our database), as described for
a cytotoxin-producing MRSA strain48. While the previously isolated
strain was resistant to fusidic acid and tetracycline, but susceptible
to erythromycin and clindamycin, we noted the presence of a common plasmid backbone in our database (Sha2 with 88 sequences)
that carried a new combination of resistance genes for all four antibiotics (Fig. 4b and Supplementary Data 4). Similarly, we observed
that ARGs found in phages, such as aac6-Aph2 and far1, tended to
be more widely present (Fig. 4 and Supplementary Fig. 13a), with
evidence for recent phage-mediated dissemination of far1 across
Staphylococcus species (Supplementary Fig. 13b). In general, ARGs
found in plasmids tended to have more ARGs in close proximity
(<10 kb apart) in chromosomes than chromosome-exclusive ARGs
(Wilcoxon test P value = 6 × 10−7), characteristic of higher gene
mobility and shuffling for plasmid-associated genes. Thus, plasmid backbones seen in the hospital environment likely represent
a more plastic framework to generate diverse ARG combinations,
many of which are not seen in genomic cassettes (25%) despite
strong overlap in the complement of ARGs that they harbor (84% of
plasmid genes).
Hospital-environment strains overlapping with patient isolates
are globally disseminated and enriched for multidrug resistance.
The availability of a large database of genomes from many species
in the hospital environment, an obvious hub for patient colonization, prompted us to ask how environmental strains are related to
patient-colonizing strains. To examine this, we constructed phylogenetic trees for environmental strains and patient isolates across
species (Fig. 5). We started with Singaporean E. anophelis isolates
from a 2012 outbreak49 (n = 10) and an additional set of patient isolates from 2009–2012 (n = 52; Fig. 5a and Methods). Despite sampling from different Singaporean hospitals after a span of 5–8 years,
patient-associated genomes matched environmental genomes with
just 16 SNPs (s1; 99.9996% ANI). The environmental E. anophelis
genomes in our studies primarily originated from sinks, which, as
noted earlier, tend to have stable communities, indicating that these
strains may have originated from a common reservoir upstream of
water-piping systems39. The E. anophelis clusters shared between
patients and the environment were also detected at the third time
point 1.5 years later (>99.999% ANI, direct transfer) and exhibited
resistance to more antibiotics than the clusters that were not shared
(1.25-foldchange; one-sided Wilcoxon P value = 0.059).
We next analyzed S. aureus genomes (n = 221) from a surveillance study of patients in the same hospital almost a decade ago50.
These strains matched 5 of 17 strains obtained in the current study,
Nature Medicine | VOL 26 | June 2020 | 941–951 | www.nature.com/naturemedicine

Content courtesy of Springer Nature, terms of use apply. Rights reserved

Articles

NATure MeDiCine
Microbial species
A. baumannii

Enterococcus spp.

S. epidermidis

E. cloacae

K. pneumoniae

S. haemolyticus

Asp

E. faecalis

S. aureus

S. hominis

E. faecium

S. capitis

S. warneri

Aminoglycosides

a

ErmB

Plasmid host species
Aba

Beta-lactams

Bth
Cfr

Antibiotic resistance class

Fluoroquinolones

Fosfomycin

Glycopeptides

Ant6-Ia

ShoC1:3

Sha

S. haemolyticus
S. hominis

Sho

Slu
Spa
Ssa
Ssi

Tetracyclines

S. lugdunensis
S. pasteuri
S. saprophyticus
S. simulans

Trimethoprim

Spc ErmA

CatA1

KpnC4:4

AacAad

SulIII
AadA

Aac6-Aph2

EclC2:5

MecA

KpnC2:5

DfrA5 CTX-M-1

Efa4:6

MsrA

EclC4:3

MphE OqxA
VanX-Yc VanR-C

EspC1:5

MsrE

OqxB

Sep11:6

Aba1:5
VanA

Sha2:88

Asp1:14
Kpn2:12

VanS
VanR
VanX

Aac6-Aph2

TetC
Bth1:24

Sau12:10

Sau8:13 Sep1:17

Far1

AbaC1:4

Spa1:24

BlaZ

StrB

StrA

SulII

VanY

MecA

Sen1:6

Sau4:10

OXA-23
TetB

TEM-1D
VanH

Efa1:10

Slu1:9

StrB

VgaA

Sha1:68

Efa3:10

Sep4:21

Slu2:10

Aph3Ia

MphE

MsrE
Sau10:5

CTX-M-1

Sho1:13

Sau13:10

Chromosomes

VanY

ArmA

Efa2:8

Sep6:17

SulII

KpnC3:5
(EclC3:5)
TetK
VanS-C
VanC1
VanT

Sep8:7
Sau6:7

CatA

Sau14:11

MphC

Sau5:9

MphC

Sau1:6

Sep3:7

TetL

StrA
AadD

Ant6-Ia

Ssa1:11

Aac3-IIa

TEM-1D

BlaZ

Aph3-III
ErmB

FloR

DfrC

ErmC
MsrA

Plasmids

Sat4A

Sat4A

TetL

VanA

Sep

Sulfonamides

Efs1:21

EclC1:6

QnrB

Dfr

VanS

S. enterica
S. aureus

Phenicols

CatBx

OXA-1

CatA

VanR

Macrolide-lincosamidestreptogramin

Sen
Sau

S. capitis
S. chromogenes
S. epidermidis

Sca
Sch

KpnC1:5

Aph3-III

EfaC2:5

Kpn

C. freundii
E. cloacae

E. faecium
E. faecalis
K. pneumoniae

TetA

EfsC2:3

Far1
VanH VanX

Efa
Efs

b

LinB

EfsC1:3

TetM

Ecl

A. baumannii
Acinetobacter spp.
B. thuringiensis

DfrC

ErmC
Sau2:17

Sep7:27

Sch1:13

Sau7:9

Ssi1:12

Sep5:11

Sau11:158
Sep10:7

TetA

Slu3:38

Sep2:10

TetK

Sau9:16

AbaC2:3

QnrB

Sep9:36

Sau3:13

Sau15:14

AadD
Sca1:12

AadB

Cfr1:5

LnuA

Kpn3:8

Asp2:29

Aac3-IIa

SHV-OKP-LEN
Ecl1:20

Oxa-1

MphA

AacAad
CatBx

Kpn1:20

DfrA5
Oxa-48

EfaC1:5

Fig. 4 | Species distribution and genomic proximity of drug resistance genes in the hospital-environment microbiome. Genomic proximity network and
clustering of ARGs based on 2,347 microbial genomes and 5,910 closed plasmid sequences obtained from the hospital environment. a, Multigraph of
genomic proximity between ARGs. Colored edges indicate gene pairs found <10 kb apart in the genomes for a species (excluding plasmids). Line widths
indicate the frequency of occurrence of gene pairs (normalized by count for the rarer gene), and frequencies >80% are marked with solid lines. Solid-line
cliques in each species were used to define cassettes and assign names (Supplementary Data 5), and the number after the colon indicates clique size.
Genes are colored according to their respective antibiotic classes. b, Circles represent different plasmid clusters (95% identity), and their corresponding
ARGs are connected by edges and indicated by diamonds. Plasmid nodes were labeled based on a three-letter short form for the host species and
assigned a number (for example, Kpn1 for a K. pneumoniae plasmid); the number after the colon indicates how many representatives of the plasmid family
were observed in the database. Edges are weighted by the frequency at which a gene is present in a plasmid, and frequencies >80% are indicated with red
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with environmental and patient genomes having just 39 SNPs and
99.9985% ANI (Fig. 5b). The co-occurrence of patient and environmental genomes was significantly enriched in multidrug-resistant
clusters at the derivative genomes threshold (for example, s1, s2
and s3; binomial test P value < 10−15). These clusters were also
enriched for genomes detected in the third time point (binomial test
P value < 2 × 10−7) with <60 SNPs (99.998% ANI) from genomes in
early time points, highlighting the stability of antibiotic-resistant
derivative clusters in the hospital environment.
To extend these observations, A. baumannii patient isolates
(n = 108) from a hospital surveillance cohort in Singapore established >8 years ago were sequenced. Many isolate genomes from
this cohort had high identity to our environmental genomes (s6,
99.995% ANI) while being temporally separated by almost a
decade. In addition, patient isolates that overlapped with environmental genomes were enriched for multidrug resistance (derivative
clusters; binomial test P value < 4 × 10−3). Extending to a regional
context, analysis of A. baumannii patient isolates (n = 36) from two
major Kuwaiti hospitals51 with our environmental genomes (Fig. 5c)
identified a shared derivative cluster resistant to all five antibiotics, including Singaporean and Kuwaiti patient isolate genomes at
high identity (s6, >99.99% ANI). This highlights the presence of
multidrug-resistant A. baumannii derivative clusters in hospital
environments that are persistent, enriched in overlap with patient
isolates and globally disseminated.
Similar patterns were observed recently for S. epidermidis lineages (ST2/ST2 mixed), which seem to have disseminated globally
within a short period of time (n = 229; ref. 29). We confirmed detection of these rifampicin-resistant29 lineages in our data (Fig. 5d),

with 80 SNPs (99.997% ANI) from our hospital-environment
genomes. One other lineage (ST16) not known to be globally disseminated (isolated from a patient sample in the United States29)
was represented by a genome in our database with similarity at
the derivative threshold (99.991% ANI). Finally, we found that
the overlap between S. epidermidis patient isolates (surveillance
samples from Austin Health in Australia29) and environmental
genomes from this study was enriched for multidrug resistance in
derivative clusters (binomial test P value < 4 × 10−12). Together with
the observation that multiantibiotic-resistant strains are persistent
and widely distributed across the hospital environment (Fig. 3d and
Supplementary Fig. 11), these data point to selective advantages for
MDROs to persist and spread in hospital environments and patients.

Discussion

While the importance of hospital design for preventing infections is known52, the utility of metagenomic surveys in medical
facilities remains underexplored12. A detailed survey helps provide a reference map (with three-dimensional (3D) visualization;
https://github.com/csb5/hospital_microbiome_explorer) that can
be updated based on periodic scans whose frequency and locations can be informed by the initial survey. For example, the turnover score and specificity of a site can determine whether and how
frequently it should be sampled. Variations in human influence
scores could fine-tune cleaning practices, and distribution of specific pathogens could inform infection control in outbreak settings.
As genomics-guided infection control advances, this knowledge
could feed back into better hospital designs. With further improvements in the cost and ease of short-read sequencing, hospital-wide
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Fig. 5 | Multispecies analysis of phylogenetic relationships between environmental and patient genomes. Phylogenies depict the evolutionary
relationships between derivative clusters (>99.99% ANI), with each node representing the consensus genome for a cluster. a, E. anophelis from a
nosocomial outbreak in Singapore in 2012 and other patient isolates from 2009–2012, b, patient-colonizing S. aureus from a 2009–2011 surveillance study
in Singaporean hospitals, c, infectious A. baumannii isolates from patients in two major Kuwaiti hospitals and Singaporean patient isolates, and d, recent
globally disseminated multidrug-resistant S. epidermidis lineages, together with environmental genomes for corresponding species from this study.
While a and b highlight the close relationships between the strains circulating in Singaporean hospitals up to 8 years apart, c and d reveal the global
dissemination of several lineages. The matrices next to the trees indicate the antibiotic resistance profiles for corresponding derivative clusters. Scale bars
depict the number of substitutions for each site in the core alignment. For all species tested, clusters shared between environmental and patient genomes
were enriched for multidrug resistance.

surveys will be increasingly feasible, provide valuable information
for infection control and eventually be part of routine practice.
The microbial community types observed here highlight distinct
niches found in hospitals compared to other urban environments,
providing an organizing principle for further study. For example,
while many pathogens were substantially enriched in hospitals,
this was also prominent in CTA sites that had a greater diversity
of ARGs (Supplementary Fig. 7c,d). Recent clinical studies have
focused on wash-area sites (such as sinks and showers; CTB sites), as
outbreak-associated pathogens are often isolated there39. This focus
on CTB sites is concordant with the presence of biofilm-forming
bacteria and their harboring viable reservoirs for extended periods
(for example, in the plumbing). Our data show that many pathogens
(for example, K. pneumoniae), ARGs (for example, carbapenemases
such as oxa-23) and ARG-containing plasmids (in >85% of sites)
are more common in CTA sites. While CTA sites have higher turnover, the detection of highly similar strains over extended periods
indicates that they have distinct reservoirs (for example, in ventilation or air-conditioning ducts) and that culture-based screening
may bias against sites with lower biomass or variable colonization.
Combining the strengths of metagenomics and culturing may therefore be needed to systematically explore the source of outbreaks.
Large-scale genomics of nosocomial pathogens through isolation can be laborious and time consuming, while metagenomics
may not provide genomes for low abundance species. The intermediate approach proposed here addresses both issues. Culture-based
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enrichment allows us to shift the distribution away from abundant
species (for example, C. acnes) and toward pathogens at low abundances (for example, K. pneumoniae, S. aureus and A. baumannii)
while allowing functional selection such as for antibiotic resistance. Culture-based enrichment in combination with long-read
metagenomics is powerful, enabling direct recovery of genomes
(chromosomal, plasmid and phage) without isolation. With further
automation (for example, library preparation), this workflow can
enable high-throughput analysis and wider surveillance, to achieve
the vision of precision epidemiology for infectious diseases53.
Future improvements in nanopore sequencing throughput and
lower DNA-input requirements could accelerate time-to-answer via
point-of-care usage and reduce or eliminate the culturing period.
The availability of many high-contiguity assemblies (>8 Gb;
2,347 genomes and 1,693 phage and 5,910 plasmid sequences) provides a unique resource for studying the distribution of strains and
diversity of ARG cassettes in the hospital environment. Leveraging
this, we observed that multidrug-resistant strains are preferentially
distributed and persistent in hospitals across a range of species.
This represents a worrisome pattern, with several explanations that
warrant investigation. One scenario is that hospitals are repeatedly
seeded by resistant strains that preferentially persist in the community (humans or environment). This explanation seems less plausible as some species where this pattern is observed are rarely found
in humans (for example, E. anophelis and A. baumannii), and it is
based on observations that other urban microbiomes are distinct
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from hospitals in taxonomic composition, the frequency at which
they harbor pathogens and diversity of ARGs. Nevertheless, this
does not rule out the possibility that urban environments (1) harbor pathogens and resistant strains at lower abundances compared
to hospitals and (2) resistant strains are also widespread and persistent in these environments. Another hypothesis is that hospital
cleaning measures select for more antibiotic-resistant organisms54,
a model that is supported by the presence of multiple copies of disinfectant resistance genes in widely distributed multidrug-resistant
S. aureus strains in our study. Comparisons with surveys from built
environments that are intensively cleaned but do not house patients
(for example, operating rooms) or are not intensively cleaned but
have high patient traffic (for example, clinic waiting areas) can help
explore this hypothesis. Studies across wards and in hospitals with
different protocols could also reveal how ARG reservoirs are shaped
by cleaning practices55.
Despite their importance as an epicenter for the battle against
growing antibiotic resistance1, hospital environments have received
little attention compared to agricultural and animal farms12.
Our analysis highlights that hospitals harbor a significant uncharacterized diversity of microbes (n = 13 novel species) and ARG
combinations (n = 255). This reservoir can be the origin of new
opportunistic infections or fertile ground for the evolution of
clinically relevant ARG combinations (for example, colistin and
fosfomycin resistance). In particular, the prevalence of plasmids
containing ARGs (n = 1,400) could enable gene transfer across species56. The development and use of anti-plasmid agents57 could thus
be a complementary strategy to curb the spread of ARGs through
hospital environments.
While most studies have focused on patient isolates58, relatedness
between environmental and patient-colonizing strains is important
for understanding the risk that environmental strains pose15,17. For
contemporary and co-located strains, high relatedness between a
subset is expected. Despite samples being separated by >8 years,
obtaining highly similar genomes suggests that large reservoirs of
multidrug-resistant strains are maintained with limited diversification. The identification and elimination of these reservoirs may
reduce the incidence of corresponding infections and the risk from
maintenance of ARGs. Another interesting observation is the high
genomic similarity between MDROs in Singaporean hospitals and
those from patients globally. The consistency of these patterns across
species emphasizes the global dissemination of newly emerging
MDRO lineages; thus, the role of hospital environments deserves
investigation, leveraging multinational metagenomic datasets26.
Overall, our data indicate selective advantages for MDROs to persist and spread in hospital environments (Fig. 3d and Supplementary
Fig. 11) and be shared with patients (Fig. 5). The S. aureus derivative clusters that persisted in the hospital are enriched in virulence
factors (1.5-fold; one-sided Wilcoxon P value = 0.015) and have
three copies of disinfectant resistance genes38,59 (Fig. 3d), potentially enabling colonization of hospital environments and patients
and facilitating transfer between them. This points to a vicious cycle
where disinfectant resistance, antibiotic resistance and virulence
may in turn be selected for, enriching for strains adept at colonizing both niches with depleted microbial competition and offering
an explanation for the high incidence of multidrug-resistant HAIs
worldwide despite increased surveillance and aggressive cleaning
measures in hospitals60.
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Methods

Sample collection and storage. Environmental swabs were collected from Tan
Tock Seng Hospital (TTSH), a major tertiary-care hospital with >2,000 patient
visits daily, serving as the national referral center for communicable diseases in
Singapore. Sampling was conducted in November 2017 and in May 2019. Samples
were collected in 2 days for the first time point and in 3 days for the second time
point, with 1 week separating the time points. The third time point was 1.5 years
later, with samples collected in 4 days across 2 weeks. Samples were collected from
isolation rooms (1 bed, typically for patients colonized with CRE), MDRO wards
(5 beds, typically for patients colonized with MRSA) and standard wards (5 beds)
at seven different sites, including the aerator, sink trap, bed rail, bedside locker,
cardiac table, pulse oximeter and door handle (Fig. 1 and Supplementary Data 1).
Standard cleaning protocols at TTSH require that high-touch areas and sinks
be cleaned daily with chlorine (5,000 ppm) and cleaning detergent, respectively,
excluding beds that are cleaned upon patient discharge. Isohelix DNA Buccal
Swabs (SK-4S) were used for sampling according to MetaSUB protocols26. Briefly,
a total of four swabs were collected; one swab (for culturing) was moistened
with 1× PBS (pH 7.2), and three swabs (two swabs for metagenomic DNA isolation
and one swab for storage) were moistened with DNA/RNA shield (Zymo Research,
ZYR.R1100-250). Swabbing was performed for 2 min in each site, and swabs were
stored in respective storage liquids (that is, 1× PBS, pH 7.2, or Zymo DNA/RNA
shield). Swabs in PBS were placed on ice and sent for culturing while the other
swabs were transported at room temperature to the laboratory and stored at
−80 °C. In total, 1,752 swabs were collected from 179 sites in the hospital at
three time points, representing 438 unique samples. Swabs were also collected
from an office environment (Genome Institute of Singapore) with sites selected
to approximately match those from which samples were collected in the hospital
(aerator, sink trap, chair handle, office desk, keyboard and door handle; n = 30;
Supplementary Data 1). MetaSUB Singapore samples were collected from
high-touch surfaces in different parts of the city and analyzed based on MetaSUB
protocols as described in Danko et al.26 (n = 99; Supplementary Data 1).
DNA extraction from swabs. DNA was extracted from swabs using a bead-beating
and automated DNA purification system. Briefly, 300 µl of lysis buffer was added to
Lysing Matrix E tubes (MP Biomedicals, 116914500). Samples were homogenized
using the FastPrep-24 instrument at 6 m s–1 for 40 s before centrifugation at
maximum speed for 5 min. The supernatant was treated with proteinase K (Qiagen
Singapore, 19133) for 20 min at 56 °C before DNA was purified with the Maxwell
RSC Blood DNA Kit (Promega, AS1400). DNA concentration was quantified
using a Qubit 2.0 fluorometer, prepared with the Qubit dsDNA HS Assay Kit
(Life Technologies, Q32854). DNA extraction from backup swabs was carried out
for samples with insufficient amounts of DNA. Samples that still had less than
0.5 ng of DNA were excluded from library preparation (10 of 438).
Illumina library preparation. Extracted DNA was sheared using Adaptive
Focused Acoustics (Covaris) with the following parameters: 240 s, duty factor of 30,
PIP of 450 and 200 cycles per burst. Metagenomic libraries for the first two time
points were prepared with the NEBNext Ultra DNA Kit (New England Biolabs,
E7370) according to the manufacturer’s instructions. Paired-end sequencing
(2 × 101-bp reads) was performed on the Illumina HiSeq2500 platform. For
the third time point, metagenomic libraries were prepared using the NEBNext
Ultra II DNA Library Prep Kit (New England Biolabs, E7645) according to the
manufacturer’s instructions. Paired-end sequencing (2 × 151-bp reads) was
performed on the Illumina HiSeq 4000 platform.
Culture enrichment. Following MetaSUB protocols, swabs were directly incubated
with 7 ml of Brain Heart Infusion (BHI) broth (Thermo Scientific Microbiology,
CM1135B) at 37 °C until turbidity was observed (14–16 h for >95% of samples),
up to a maximum of 48 h. Culture tubes were centrifuged at 3,200g for 12 min.
For the first two time points, cell pellets were resuspended with 550 µl of 1× PBS,
while the cell pellets for the third time point were resuspended with 1 ml of 1×
PBS. Fifty microliters of resuspended cultures was then plated on each of six agar
plates (without antibiotics, BHI; ampicillin: 100 µg ml–1, AMP; streptomycin sulfate:
100 µg ml–1, STREP; tetracycline: 10 µg ml–1, TET; kanamycin: 50 µg ml–1, KAN;
and chloramphenicol: 35 µg ml–1, CHLOR), and plates were incubated overnight
at 37 °C. Cells were harvested by a plate sweep and were pelleted by centrifugation
at 8,000g for 15 min at 4 °C for the first two time points. For the third time point, a
loopful of harvested cells was streaked out on an antibiotic-free BHI plate to obtain
single colonies for whole-genome sequencing. Plates were only excluded if no cells
were growing on the plates or when the growth was insufficient to generate enough
DNA for sequencing.
DNA extraction from enrichment cultures. Frozen cells were thawed on ice
and manually mixed with a wide-bore pipette tip. A volume of 30–50 µl of cells
was resuspended in 100 µl of 1× PBS (pH 7.4). Twenty microliters of suspended
cells was added to 20 µl of metapolyzyme (6.7 µg µl–1; Sigma Aldrich, MAC4L).
The mixture was incubated at 35 °C for 4 h. RNase treatment was carried out by
adding 350 µl of 1× TE buffer and 10 µl of RNase A (4 mg µl–1) and incubating on
a rotator for 10 min at room temperature. DNA was extracted with the Maxwell

RSC Cultured Cells Kit (Promega, AS1620). DNA was cleaned up and concentrated
with 0.4× Agencourt AMPure XP beads (Beckman Coulter, A63882). DNA purity
and concentration were measured with a NanoDrop and Qubit fluorometer. DNA
integrity was assessed on a 0.5% agarose gel. DNA samples with the following
quality measurements were selected for nanopore sequencing: DNA amount:
>400 ng; A260/280: 1.8–2.0; A260/230: 1.7–3.0; Qubit:NanoDrop: 0.7–1.3; DNA
integrity on 0.5% agarose gel: >1 kb. The Qubit:NanoDrop ratio was used to
estimate and control the amount of single-stranded DNA in the sample and ensure
successful nanopore sequencing.
Collection and testing of bacterial isolates from patients. E. anophelis isolates
(n = 52) were obtained from consecutive positive blood cultures and respiratory
samples collected in a 3-year period (2009–2012) at the National University
Hospital in Singapore (DSRB reference 2017/00879). A. baumannii complex
isolates (n = 108) were consecutively obtained from all clinical specimens
(including blood, tissue, respiratory and urine samples) sent for routine bacterial
culture between February 2009 and May 2009 at the Singapore General Hospital
Diagnostic Bacteriology Laboratory (de-identified and archived, hence institutional
review board approval was not required). Antibiotic susceptibility testing for
E. anophelis isolates was performed with 13 antimicrobial agents (cefotaxime,
ceftazadime, cefepime, imipenem, meropenem, ampicillin-sulbactam, piperacillin/
tazobactam, tigecycline, gentamicin, nalidixic acid, ciprofloxacin, levofloxacin
and trimethoprim/sulfamethoxazole) using Etest strips (bioMérieux). Minimum
inhibitory concentrations (MICs) were interpreted according to the Clinical and
Laboratory Standards Institute (CLSI) guidelines for non-Enterobacteriaceae
Gram-negative bacilli (performance standards for antimicrobial susceptibility
testing, M100-S22 and CLSI 2012; Supplementary Data 6). Antibiotics to which
all strains were resistant were excluded from statistical analysis. Antibiotic
susceptibility testing for A. baumannii complex isolates was conducted with 11
antimicrobial agents (ampicillin/sulbactam, piperacillin/tazobactam, cefepime,
imipenem, gentamicin, amikacin, ciprofloxacin, levofloxacin, trimethoprim/
sulfamethoxazole, minocycline and polymixin B). Polymixin B susceptibility
testing was performed using Etest strips (bioMérieux), and disk diffusion was
performed for all other antimicrobial agents. Polymixin B MICs and zone
diameters for all other tested agents were interpreted in accordance with CLSI
breakpoints for Acinetobacter spp. (performance standards for antimicrobial
susceptibility testing, M100-S19 and CLSI 2009; Supplementary Data 6).
Multidrug-resistant status for patient isolates were defined according to US Centers
for Disease Control and Prevention (CDC) guidelines (https://www.cdc.gov/nhsn/
pdfs/ps-analysis-resources/phenotype_definitions.pdf).
DNA extraction for bacterial isolates. Cell pellets were allowed to thaw slowly on
ice and resuspended in 400 µl of ATL buffer (Qiagen Singapore, 19076). Cells were
lysed in Lysing Matrix E tubes (MP Biomedicals, 116914500) on a vortex adapter
at maximum speed for 10 min. Cell lysates were centrifuged at 16,000g for 5 min,
and supernatant was treated with 4 µl of RNase A (100 mg ml–1; Qiagen Singapore,
19101), gently mixed by flicking of the tube and incubated at room temperature
for 2 min. The cell lysate was further treated with 25 µl of proteinase K (20 mg ml–1;
Qiagen Singapore, 19133), gently mixed by flicking of the tube and incubated at
56 °C for 20 min. DNA was purified twice using 1 volume of AMPure XP beads
(Beckman Coulter, A63882) with slight modifications to the manufacturer’s
protocol. All mixing steps were replaced with gentle flicking of the tube and
incubation on the hula rotor for gentle mixing. Fresh 70% ethanol was prepared
for washing, and magnetic beads were incubated on a 37 °C heat block for 3–5 min
to dry off residual ethanol. The quality and quantity of DNA were assessed using a
NanoDrop, Qubit fluorometer and 0.5% agarose gel. Samples that were unable to
pass the following criteria were omitted from sequencing: DNA amount measured
by Qubit: >510 ng; DNA concentration measured by Qubit: >11 ng µl–1. A260/280
ratio: between 1.7–2.0; A260/230 ratio: between 1.5–3.3; and DNA length: >1 kb.
Purified DNA was stored at 4 °C.
Nanopore library preparation. DNA was prepared with either the 1D2 sequencing
kit (SQK-LSK308) or the 1D sequencing kit (SQK-LSK108 or SQK-LSK109)
together with the native barcoding kit (EXP-NBD103 or EXP-NBD104 and
EXP-NBD114) according to the native barcoding genomic DNA protocol. DNA
was not sheared and was used directly for DNA repair and end preparation. Both
native barcode ligation and adaptor ligation steps were extended to 30 min instead
of 10 min. In addition, to maximize library yields, more than 700 ng of pooled
sample (where possible) was used for adaptor ligation. Samples were multiplexed
(9–12 samples for each pool for culture-enriched samples and 24 samples for each
pool for isolates) and sequenced with MIN106, MIN106D or MIN107 flowcells on
a GridION machine.
Taxonomic and resistome profiling with Illumina shotgun metagenomic
data. Illumina shotgun metagenomic sequencing reads were processed using
a Snakemake pipeline (https://github.com/gis-rpd/pipelines/tree/master/
metagenomics/shotgun-metagenomics). Briefly, raw reads were filtered to remove
low-quality bases using skewer (v0.2.2; -q 3 -l 30 -n) and human reads were
removed by mapping to the hg19 reference using BWA-MEM (v0.7.10-r789).
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The remaining microbial reads were profiled with MetaPhlAn2 (ref. 61; v2.6.0)
and SRST2 (ref. 62; v0.1.4; --min_coverage 100, hits with identity <99% were
filtered out) for taxonomic and ARG abundances, respectively. Microbial reads
were also assembled using MEGAHIT (v1.0.4-beta; default parameters) for
comparison to nanopore assemblies. The site specificity score was computed as the
z-score for the closest taxonomic profile for a sample (Bray–Curtis dissimilarity)
among physically proximal sites (in the same room or cubicle and at the same
time point), compared to the distribution of Bray–Curtis dissimilarities across all
samples of a site (for example, all bed rails). Results based on analysis of taxonomic
and resistome profiles were obtained for each time point independently and
compared across time points to check for consistency and filter out potential
sequencing artefacts23.
Removal of likely contaminant species. Likely contaminant species were
identified based on batch and correlation analysis23 (Supplementary Note 2) and
were removed from species-level abundance profiles. For genus-level profiles,
relative abundances of the filtered species were subtracted from the abundance of
the corresponding genera for each sample. Filtered profiles were then renormalized
to sum to 100% and used for all downstream analyses.
Preprocessing of nanopore sequencing data. Raw nanopore reads were
base-called with the latest version of the basecaller available at the point of
sequencing (Guppy v0.5.1 to v3.0.6 or Albacore v2.3.1 to v2.3.3, for libraries that
failed live base-calling). Base-called nanopore reads were demultiplexed and
filtered for adaptors with Porechop (v0.2.3; https://github.com/rrwick/Porechop)
or qcat (v.1.1.0; https://github.com/nanoporetech/qcat). Sequencing statistics were
summarized using SeqKit (v0.10.1). Reads were taxonomically classified with
Kraken63 (v0.10.5-beta) against the miniKraken database to assess the diversity of
cultures on the plates (minikraken_201711_01_8GB_dustmasked).
Genome assembly and species assignment. Nanopore reads for each plate
were assembled using Canu64 (v1.3 and v1.7; genomeSize = 8 m). For samples
where both Illumina and nanopore reads were available, a higher-quality hybrid
assembly was obtained using OPERA-MS19 (v0.8.3; --polish --no-gap-filling
--short-read-assembler spades). Assembled contigs were mapped to the NCBI
nt database with BLAST (v2.2.28), to identify microbial species or plasmid
assignments according to the best BLAST hit (highest total reference coverage).
Circular sequences were identified using MUMmer65 (v3.23; --maxmatch
--nosimplify, alignments <1 kb long or with identity <95% were filtered out) as
recommended in the documentation for Canu (https://canu.readthedocs.io/en/
latest/faq.html#my-circular-element-is-duplicated-has-overlap). Contigs assigned
to the same species were binned into genomic bins. Metagenomic Illumina reads
were used to polish Canu assemblies where feasible using Pilon66 (v1.22; --fix
indel). We noted that annotation errors were substantially reduced after polishing
and that genomic bins whose length was within 10% of the expected length
met the criteria for high-quality genomes (completeness > 90% and contamination
< 5% using CheckM67; v1.0.7; --reduced_tree). Genomic bins that met these
criteria were therefore designated as high quality, and incomplete bins (<50%
of the expected length) were removed from further analysis. Genomes
corresponding to novel species were identified as those with identity <95% or
coverage <80% when compared with known genomes (BLAST with nt) and three
recent catalogs that include environmental and human microbiome assembled
genomes31–33 (with Mash68). The genomes were hierarchically clustered (single
linkage with Mash distance68) to identify species-level clusters at 95% identity, and
genus-level taxonomic classification was obtained using sourmash69. Similarly,
novel circular plasmids were identified by comparing to the PLSDB36 database
with Mash distance and identifying clusters at 99% identity (single linkage)
with no known sequence.
Analysis of ARG combinations. ARGs were annotated to contigs by mapping
them to the ARG-ANNOT70 database provided in SRST2 (v3) with BLAST (best
hit with >90% identity and >90% reference coverage). ARG combinations present
in chromosomes and plasmid sequences were considered novel when they were
not found in the reference databases (nt or PLSDB36). Assembled circular plasmids
were clustered and annotated based on their best BLAST hit with identity >95%
and >60% query coverage. A bipartite graph was constructed by connecting each
plasmid cluster to ARGs found in it, with edge weights representing the frequency
of occurrence (clusters with <5 representatives were excluded). For each species, an
ARG co-occurrence graph was created for ARGs found in the assembled genomes
by connecting the ARG pairs that were found within 10 kb on the same contig
(discarding ARG pairs occurring fewer than five times). Each edge was weighted
by the frequency of ARG pairs divided by the minimal frequency of the two ARGs.
All ARG co-occurrence graphs were merged into a final co-occurrence multigraph.
The graphs were visualized using Cytoscape (v3.7.1).
Analysis of virulence factor and biocide resistance genes. Nanopore assemblies
were aligned to virulence factors in the PATRIC database71 (20 December 2018)
with DIAMOND (v0.9.24.125; blastx --long-reads), and alignments with E
value > 0.001 were filtered out. To identify biocide resistance genes, the assemblies

were aligned to nucleotide sequences for the genes qacA (NC_014369.1) and qacC
(NC_013339.1) with BLAST (>90% identity and >90% reference coverage).
Analysis of phages and prophages. Phage-like elements (phages and prophages)
were identified using VirSorter72 (v1.0.5; phages and prophages in category 3 or
with length <10 kb were filtered out). The assembled phages and reference phages
from the MVP database37 were hierarchically clustered (single linkage with Mash
distance68) to identify phage clusters at 95% identity. Clusters without any phages
from the reference database were considered novel. For each cluster, subclusters
were defined at 99.9% ANI by single-linkage clustering with nucleotide identities
from nucmer (--maxmatch --nosimplify, followed by dnadiff and minimum
sequence overlap of 80%). Phage-like elements were annotated using RAST73
(virus domain, fix frame-shifts parameters).
Analysis of patient isolates and strain relationships. Raw reads corresponding
to genomes for outbreak isolates29,49–51 were downloaded and assembled
using the Velvet assembler (v1.2.10) with parameters optimized by Velvet
Optimiser (k-mer length: ranging from 81–127), scaffolded with OPERA-LG74
(v1.4.1) and gap-filled with FinIS75 (v0.3). Outbreak genomes from the same
species were jointly analyzed with high-quality genomes from the hospital
environment. To identify high-confidence SNPs, we adapted the method
from Brooks et al.17. Specifically, we performed pairwise alignments between
genomes using nucmer and considered genome pairs with alignment coverage
> 80% for ANI computation. SNPs between genome pairs were called
using MUMmer’s ‘show-snps’ function, and regions containing more than
one SNP within 20 bp were filtered out to mask potential artefacts from
horizontal gene transfer, recombination or repeats. Finally, the genomic
distance matrix (number of SNPs/alignment size) was clustered hierarchically
(single linkage) and clusters were obtained at 99.99% identity for species
with hybrid assemblies (nanopore and Illumina) or at 99.9% identity for
species with nanopore-only assemblies. Single-linkage clustering was used
to avoid having highly similar genomes assigned to separate clusters, and we
confirmed that despite this, most members (99%) had an average distance to
other members of the cluster below the clustering thresholds used. Antibiotic
resistance profiles and multidrug resistance status (>2 antibiotic types) for
each cluster were derived from the union of resistance profiles for each genome
obtained in various selection plates.
For phylogenetic analysis, a consensus genome was derived for each cluster
based on reference-guided alignment with nucmer (S. aureus: NC_020529;
S. epidermidis: NC_004461; E. anophelis: NZ_CP007547; E. faecalis: NC_017312;
E. faecium: NC_017960; P. aeruginosa: NC_018080; K. pneumoniae: NC_018522;
and A. baumannii: NC_009085) and the cons utility in the EMBOSS suite.
Maximum-likelihood phylogenetic trees were constructed for each species with
Parsnp76 (v1.2; -c -x; accounting for recombination events using PhiPack77) based
on consensus genomes for each cluster, where multiple-sequence alignments for
each species varied in length from 0.6 Mb (S. epidermidis) to 5.1 Mb (P. aeruginosa).
For the species-level tree, full-length 16S rRNA sequences (S. epidermidis:
L37605.1; S. aureus: NR_118997.2; E. anophelis: NR_116021.1; and A. baumannii:
NR_026206.1) were aligned with MAFFT (v7.154b; default parameters) and the
phylogeny was determined using FastTree2 (ref. 78; v2.1.8; default parameters).
The trees were visualized using the ‘ggtree’ R package79. Strain distributions across
sites were visualized with the ‘HiveR’ R package (https://github.com/bryanhanson/
HiveR). Rarefaction analysis for species, plasmids, strains and resistance genes was
performed using the iNEXT R package80.
Statistical analysis. Statistical tests were performed using R and were two
sided unless otherwise specified. For enrichment analysis at the cluster level
(overlap across time, cohorts or resistance status), Fisher’s exact test was used.
The binomial test was used for analysis at the genome level (fraction of genomes
with a specific property).
Reporting Summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.

Data availability

Sequencing reads and assemblies are available from the European Nucleotide
Archive under project PRJEB31632. Source code and data for reproducing figures
are available under MIT license at https://github.com/csb5/hospital_microbiome.
Assemblies and annotations for genomes, plasmids and phages are available at
https://t.co/bdZxADGM7z.

References

61. Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic
profiling. Nat. Methods 12, 902–903 (2015).
62. Inouye, M. et al. SRST2: rapid genomic surveillance for public health and
hospital microbiology labs. Genome Med. 6, 90 (2014).
63. Wood, D. E. & Salzberg, S. L. Kraken: ultrafast metagenomic sequence
classification using exact alignments. Genome Biol. 15, r46 (2014).

Nature Medicine | www.nature.com/naturemedicine

Content courtesy of Springer Nature, terms of use apply. Rights reserved

Articles

NATure MeDiCine

64. Koren, S. et al. Canu: scalable and accurate long-read assembly via adaptive
k-mer weighting and repeat separation. Genome Res. 27, 722–736 (2017).
65. Kurtz, S. et al. Versatile and open software for comparing large genomes.
Genome Biol. 5, r12 (2004).
66. Walker, B. J. et al. Pilon: an integrated tool for comprehensive microbial
variant detection and genome assembly improvement. PLoS ONE 9,
e112963 (2014).
67. Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P. & Tyson, G. W.
CheckM: assessing the quality of microbial genomes recovered from isolates,
single cells, and metagenomes. Genome Res. 25, 1043–1055 (2015).
68. Ondov, B. D. et al. Mash: fast genome and metagenome distance estimation
using MinHash. Genome Biol. 17, 132 (2016).
69. Pierce, N. T., Irber, L., Reiter, T., Brooks, P. & Brown, C. T. Large-scale
sequence comparisons with sourmash. F1000Res 8, 1006 (2019).
70. Gupta, S. K. et al. ARG-ANNOT, a new bioinformatic tool to discover
antibiotic resistance genes in bacterial genomes. Antimicrob. Agents
Chemother. 58, 212–220 (2014).
71. Wattam, A. R. et al. PATRIC, the bacterial bioinformatics database and
analysis resource. Nucleic Acids Res. 42, D581–D591 (2014).
72. Roux, S., Enault, F., Hurwitz, B. L. & Sullivan, M. B. VirSorter: mining viral
signal from microbial genomic data. PeerJ 3, e985 (2015).
73. Aziz, R. K. et al. The RAST Server: rapid annotations using subsystems
technology. BMC Genomics 9, 75 (2008).
74. Gao, S., Bertrand, D., Chia, B. K. & Nagarajan, N. OPERA-LG: efficient and
exact scaffolding of large, repeat-rich eukaryotic genomes with performance
guarantees. Genome Biol. 17, 102 (2016).
75. Gao, S., Bertrand, D., & Nagarajan, N. FinIS: improved in silico finishing
using an exact quadratic programming formulation. In Algorithms in
Bioinformatics (Eds. Raphael, B. & Tang, J.) 314–325 (Springer, 2012).
76. Treangen, T. J., Ondov, B. D., Koren, S. & Phillippy, A. M. The Harvest suite
for rapid core-genome alignment and visualization of thousands of
intraspecific microbial genomes. Genome Biol. 15, 524 (2014).
77. Bruen, T. C., Philippe, H. & Bryant, D. A simple and robust statistical test for
detecting the presence of recombination. Genetics 172, 2665–2681 (2006).
78. Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2—approximately
maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).
79. Yu, G., Lam, T. T., Zhu, H. & Guan, Y. Two methods for mapping and
visualizing associated data on phylogeny using ggtree. Mol. Biol. Evol. 35,
3041–3043 (2018).

80. Hsieh, T. C., Ma, K. H. & Chao, A. iNEXT: an R package for rarefaction and
extrapolation of species diversity (Hill numbers). Methods Ecol. Evol. 7,
1451–1456 (2016).

Acknowledgements

Funding for this work was provided by A*STAR (N.N.), and we are grateful for support
from NMRC (NMRC CGAug16C005: O.T.N. and K.M.). C.E.M. acknowledges
support from the WorldQuant Foundation, the Bill and Melinda Gates Foundation
(OPP1151054) and the Alfred P. Sloan Foundation (G-2015-13964). The funders had no
role in the study design, data collection and analysis, decision to publish or preparation
of the manuscript. We would like to thank J. Gilbert for insightful comments and
feedback on this work.

Author contributions

N.N., S.L.C., B.A., K.M. and O.T.N. planned and designed the project. A.H.Q.N.,
J.S.K. and E.X.P.H. conducted wet-lab experiments with K.R.C. and N.N.’s supervision.
H.M.L. performed nanopore sequencing under C.C.K.’s supervision. K.R.C.,
C.L. and D.B. coordinated all computational analysis with help from C.T., M.N.,
M.H.Z. and T.V.A.-S., and N.N.’s guidance. The 3D visualization tool was developed
by L.X. with C.L.’s guidance. K.K.K.K. and J.W.P.T. collected clinical isolates and
antibiotic resistance information. M.C. and C.E.M. provided guidance on environmental
sampling protocols. K.R.C., D.B., C.L. and N.N. wrote the manuscript with input
from all authors.

Competing interests

The authors declare no competing interests.

Additional information

Supplementary information is available for this paper at https://doi.org/10.1038/
s41591-020-0894-4.
Correspondence and requests for materials should be addressed to N.N.
Peer review information Alison Farrell was the primary editor on this article and
managed its editorial process and peer review in collaboration with the rest of the
editorial team.
Reprints and permissions information is available at www.nature.com/reprints.

Nature Medicine | www.nature.com/naturemedicine

Content courtesy of Springer Nature, terms of use apply. Rights reserved

Last updated by author(s): Apr 10, 2020

Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency
in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.

Statistics

nature research | reporting summary

Corresponding author(s): Niranjan Nagarajan

For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.

A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient)
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted
Give P values as exact values whenever suitable.

For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.

Software and code
Policy information about availability of computer code
Data collection

Nanopore signal data was basecalled using Albacore (v2.3.1 to v2.3.3 ) or Guppy (v0.5.1 to v3.0.6) and fastq files were generated using
Albacore and Porechop (v0.2.3).

Data analysis

Sequencing data was assembled using MEGAHIT (v 1.0.4-beta, Illumina) or Canu (v1.3/v1.7, Nanopore) or OPERA-MS (v0.8.3, Hybrid). The
assemblies were further processed and analyzed using the following software: Pilon (v1.22), CheckM (v1.0.7), Mash (v1.1.1), sourmash
(v3.0.1), blastn (v2.2.28), DIAMOND (v0.9.24.125) and MUMmer (v3.23), VirSorter (v1.0.5). Illumina shotgun metagenomic reads were
analyzed with skewer (v0.2.2), bwa mem (v0.7.10-r789), MetaPhlAn2 (v2.6.0) and srst2 (v0.1.4). Nanopore metagenomes were profiled
with kraken (v0.10.5-beta). Scripts for generation of figures are available on GitHub (https://github.com/csb5/hospital_microbiome).

For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers.
We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.

Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:

All sequencing reads are available from the European Nucleotide Archive (ENA) under project PRJEB31632 (https://www.ebi.ac.uk/ena/data/view/PRJEB31632).

October 2018

- Accession codes, unique identifiers, or web links for publicly available datasets
- A list of figures that have associated raw data
- A description of any restrictions on data availability

1

Content courtesy of Springer Nature, terms of use apply. Rights reserved

Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
Life sciences

Behavioural & social sciences

Ecological, evolutionary & environmental sciences

For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf

Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size

No statistical analysis was used to predetermine sample size. Sample size was determined based on available resources. Analysis of generated
data via rarefaction showed that the sample size was largely adequate.

Data exclusions

Samples that did not generate enough DNA for sequencing had to be excluded as library preparation for them would inevitably fail.

Replication

No technical replication was attempted for environmental sampling and culture enrichment.

Randomization

No randomization was required as the study design was observational.

Blinding

No blinding was planned as the study design was observational.

nature research | reporting summary

Field-specific reporting

Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material,
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response.

Materials & experimental systems

Methods

n/a Involved in the study

n/a Involved in the study

Antibodies

ChIP-seq

Eukaryotic cell lines

Flow cytometry

Palaeontology

MRI-based neuroimaging

Animals and other organisms
Human research participants
Clinical data

October 2018

2

Content courtesy of Springer Nature, terms of use apply. Rights reserved

Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers and authorised users (“Users”), for small-scale
personal, non-commercial use provided that all copyright, trade and service marks and other proprietary notices are maintained. By accessing,
sharing, receiving or otherwise using the Springer Nature journal content you agree to these terms of use (“Terms”). For these purposes, Springer
Nature considers academic use (by researchers and students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and conditions, a relevant site licence or a personal
subscription. These Terms will prevail over any conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription (to
the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of the Creative Commons license used will apply.
We collect and use personal data to provide access to the Springer Nature journal content. We may also use these personal data internally within
ResearchGate and Springer Nature and as agreed share it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not
otherwise disclose your personal data outside the ResearchGate or the Springer Nature group of companies unless we have your permission as
detailed in the Privacy Policy.
While Users may use the Springer Nature journal content for small scale, personal non-commercial use, it is important to note that Users may not:
1. use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access control;
2. use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
otherwise unlawful;
3. falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
writing;
4. use bots or other automated methods to access the content or redirect messages
5. override any security feature or exclusionary protocol; or
6. share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal content.
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue, royalties,
rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal content cannot be
used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any other, institutional
repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not obligated to publish any information or content on
this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature may revoke this
licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied with
respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law, including
merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed from
third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at
onlineservice@springernature.com

